产品特点
AN: 00347/2013
Revised: August 2013
Page
1
of
6
SUMMARY OF THE PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Efex 100 mg chewable tablets for dogs
Efex vet 100 mg chewable tablets for dogs (FI, SE)
Axor vet 100 mg chewable tablets for dogs (NO)
Axor 100 mg chewable tablets for dogs (DK)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains:
ACTIVE SUBSTANCE:
Marbofloxacin .................................................. 100.0 mg
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet
Clover-shaped scored beige tablet. The tablet can be divided into four equal parts
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES
In dogs
Marbofloxacin is indicated in the treatment of:
- skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis,
furunculosis, cellulitis) caused by susceptible strains of _organisms._
- urinary tract infections (UTI) caused by susceptible strains of organisms
associated or not with prostatitis or epididymitis.
- respiratory tract infections caused by susceptible strains of _organisms_.
4.3 CONTRAINDICATIONS
AN: 00347/2013
Revised: August 2013
Page
2
of
6
Do not use in dogs aged less than 12 months, or less than 18 months for giant
breeds of dogs with a longer growth period.
Do not use in cases of hypersensitivity to (fluoro)quinolones.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
A low urinary pH could have an inhibitory effect on the activity of marbofloxacin.
4.5 SPECIAL PRECAUTIONS FOR USE
(I)
阅读完整的文件